328 related articles for article (PubMed ID: 33920322)
1. Simultaneous Identification of
Zhang T; Xu Z; Liu G; Jiang B; de Bock GH; Groen HJM; Vliegenthart R; Xie X
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33920322
[TBL] [Abstract][Full Text] [Related]
2. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
[TBL] [Abstract][Full Text] [Related]
3. Machine Learning-Based Radiomics Signatures for EGFR and KRAS Mutations Prediction in Non-Small-Cell Lung Cancer.
Le NQK; Kha QH; Nguyen VH; Chen YC; Cheng SJ; Chen CY
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502160
[TBL] [Abstract][Full Text] [Related]
4. CT-based non-invasive identification of the most common gene mutation status in patients with non-small cell lung cancer.
Chen Z; Gao S; Ding C; Luo T; Xu J; Xu S; Li S
Med Phys; 2024 Mar; 51(3):1872-1882. PubMed ID: 37706584
[TBL] [Abstract][Full Text] [Related]
5. Impact of feature harmonization on radiogenomics analysis: Prediction of EGFR and KRAS mutations from non-small cell lung cancer PET/CT images.
Shiri I; Amini M; Nazari M; Hajianfar G; Haddadi Avval A; Abdollahi H; Oveisi M; Arabi H; Rahmim A; Zaidi H
Comput Biol Med; 2022 Mar; 142():105230. PubMed ID: 35051856
[TBL] [Abstract][Full Text] [Related]
6. Contrast Enhanced CT Radiogenomics in a Retrospective NSCLC Cohort: Models, Attempted Validation of a Published Model and the Relevance of the Clinical Context.
Kohan A; Hinzpeter R; Kulanthaivelu R; Mirshahvalad SA; Avery L; Tsao M; Li Q; Ortega C; Metser U; Hope A; Veit-Haibach P
Acad Radiol; 2024 Feb; ():. PubMed ID: 38383258
[TBL] [Abstract][Full Text] [Related]
7. Multisequence MRI-based radiomics signature as potential biomarkers for differentiating KRAS mutations in non-small cell lung cancer with brain metastases.
Lv X; Li Y; Wang B; Wang Y; Xu Z; Hou D
Eur J Radiol Open; 2024 Jun; 12():100548. PubMed ID: 38298532
[TBL] [Abstract][Full Text] [Related]
8. PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers.
Jin G; Kim MJ; Jeon HS; Choi JE; Kim DS; Lee EB; Cha SI; Yoon GS; Kim CH; Jung TH; Park JY
Lung Cancer; 2010 Sep; 69(3):279-83. PubMed ID: 20018398
[TBL] [Abstract][Full Text] [Related]
9. Associations Between Somatic Mutations and Metabolic Imaging Phenotypes in Non-Small Cell Lung Cancer.
Yip SS; Kim J; Coroller TP; Parmar C; Velazquez ER; Huynh E; Mak RH; Aerts HJ
J Nucl Med; 2017 Apr; 58(4):569-576. PubMed ID: 27688480
[TBL] [Abstract][Full Text] [Related]
10. CT-based radiomic phenotypes of lung adenocarcinoma: a preliminary comparative analysis with targeted next-generation sequencing.
Liu X; Xu T; Wang S; Chen Y; Jiang C; Xu W; Gong J
Front Med (Lausanne); 2023; 10():1191019. PubMed ID: 37663660
[TBL] [Abstract][Full Text] [Related]
11. Detection of
Omura K; Murakami Y; Hashimoto K; Takahashi H; Suzuki R; Yoshioka Y; Oguchi M; Ichinose J; Matsuura Y; Nakao M; Okumura S; Mun M
Transl Cancer Res; 2023 Apr; 12(4):837-847. PubMed ID: 37180673
[TBL] [Abstract][Full Text] [Related]
12. Radiogenomic System for Non-Invasive Identification of Multiple Actionable Mutations and PD-L1 Expression in Non-Small Cell Lung Cancer Based on CT Images.
Shao J; Ma J; Zhang S; Li J; Dai H; Liang S; Yu Y; Li W; Wang C
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230746
[TBL] [Abstract][Full Text] [Related]
13. Molecular typing of lung adenocarcinoma with computed tomography and CT image-based radiomics: a narrative review of research progress and prospects.
Ma JW; Li M
Transl Cancer Res; 2021 Sep; 10(9):4217-4231. PubMed ID: 35116717
[TBL] [Abstract][Full Text] [Related]
14. Predictive Power of a Radiomic Signature Based on
Li X; Yin G; Zhang Y; Dai D; Liu J; Chen P; Zhu L; Ma W; Xu W
Front Oncol; 2019; 9():1062. PubMed ID: 31681597
[TBL] [Abstract][Full Text] [Related]
15. A computed tomography (CT)-derived radiomics approach for predicting primary co-mutations involving
Zhu Y; Guo YB; Xu D; Zhang J; Liu ZG; Wu X; Yang XY; Chang DD; Xu M; Yan J; Ke ZF; Feng ST; Liu YL
Ann Transl Med; 2021 Apr; 9(7):545. PubMed ID: 33987243
[TBL] [Abstract][Full Text] [Related]
16. Clinical and radiological predictors of epidermal growth factor receptor mutation in nonsmall cell lung cancer.
Dang Y; Wang R; Qian K; Lu J; Zhang H; Zhang Y
J Appl Clin Med Phys; 2021 Jan; 22(1):271-280. PubMed ID: 33314737
[TBL] [Abstract][Full Text] [Related]
17. Next‑generation sequencing‑based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her‑2 and TP53 mutations in patients with non‑small cell lung cancer.
Jing C; Mao X; Wang Z; Sun K; Ma R; Wu J; Cao H
Mol Med Rep; 2018 Aug; 18(2):2191-2197. PubMed ID: 29956783
[TBL] [Abstract][Full Text] [Related]
18. The Potential of Radiomics Nomogram in Non-invasively Prediction of Epidermal Growth Factor Receptor Mutation Status and Subtypes in Lung Adenocarcinoma.
Zhao W; Wu Y; Xu Y; Sun Y; Gao P; Tan M; Ma W; Li C; Jin L; Hua Y; Liu J; Li M
Front Oncol; 2019; 9():1485. PubMed ID: 31993370
[No Abstract] [Full Text] [Related]
19. K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways.
Scheffler M; Ihle MA; Hein R; Merkelbach-Bruse S; Scheel AH; Siemanowski J; Brägelmann J; Kron A; Abedpour N; Ueckeroth F; Schüller M; Koleczko S; Michels S; Fassunke J; Pasternack H; Heydt C; Serke M; Fischer R; Schulte W; Gerigk U; Nogova L; Ko YD; Abdulla DSY; Riedel R; Kambartel KO; Lorenz J; Sauerland I; Randerath W; Kaminsky B; Hagmeyer L; Grohé C; Eisert A; Frank R; Gogl L; Schaepers C; Holzem A; Hellmich M; Thomas RK; Peifer M; Sos ML; Büttner R; Wolf J
J Thorac Oncol; 2019 Apr; 14(4):606-616. PubMed ID: 30605727
[TBL] [Abstract][Full Text] [Related]
20. Determination of
Papadopoulou E; Tsoulos N; Tsirigoti A; Apessos A; Agiannitopoulos K; Metaxa-Mariatou V; Zarogoulidis K; Zarogoulidis P; Kasarakis D; Kakolyris S; Dahabreh J; Vlastos F; Zoublios C; Rapti A; Papageorgiou NG; Veldekis D; Gaga M; Aravantinos G; Karavasilis V; Karagiannidis N; Nasioulas G
Oncol Lett; 2015 Oct; 10(4):2176-2184. PubMed ID: 26622815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]